Markers of differentiation are increased in NSCs and markers of pluripotency are decreased. by Natalya A. Ortolano (10291721)

Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

HAstV-1 infection leads to a decrease in epithelial markers while increasing mesenchymal markers. by Virginia Hargest (12447014)

PDRN decreases the expression of cellular aging markers. by Jingjing Chen (293564)

KDM6A mRNA expression is decreased in PTFE mice. by Simon Lebek (9756148)

Subjects:

The expression of human muscle stem cell markers. by Naoki Suzuki (308620)

Subjects:

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

Adjusted odds ratios and 95% confidence intervals for the association of pancreatic cancer with a 1 kg/m2 decrease in body mass index (BMI) between cases and controls (blue circles) and a 1 mmol/mol increase in glycated haemoglobin (HbA1c) (green squares) from 5 years before pancreatic cancer diagnosis. by Agnieszka Lemanska (13911532)

Increased growth of Mtb-LT strains in macrophages is linked to increased lipid droplet accumulation. by Sheetal Verma (5225192)

Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

Transcriptional and translational markers of syncytialization and biochemical differentiation are significantly decreased by rotenone. by O’Llenecia S. Walker (8486163)

Decrease in the interscale differentiation marker in senescence prone SAMP8 mice. by Gopakumar Changarathil (3479078)

1,25D and phosphate treatment of Ocy454 cells decreases expression of genes implicated in perilacunar matrix resorption. by Ye Yuan (531126)

Changes in glycometabolism, cytokines, oxidative stress markers, and inflammation marker between baseline and 24 weeks in patients receiving anagliptin. by Takeshi Onoue (8367606)

The level of miRNA 221 in the myocardium of MIRI mice was decreased. by Hongyu Li (1332669)

<i>SOX2</i> knockdown decreases OSCC cell migration and EMT. by Alessandro Sacco (8799386)

KAP assessment scores (n = 422). by Chikondi Maluwa (20660522)

Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)

Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice. by Katherine R. Sadleir (12035242)

“…Similarly, BACE1, LAMP1 and LC3B-II/ LC3B-I were also increased in nimodipine-treated 5XFAD compared to nimodipine treated non-transgenic mice, indicating that nimodipine did not decrease the accumulation of these dystrophic neurite marker proteins. …”

Macrophage-specific IGF-1 overexpression decreases plaque MMP8 and. by Patricia Snarski (22305205)